SECTOR KNOWLEDGE / CONSUMER HEALTHCARE

Consumer Healthcare

OUR PERSPECTIVE
Advisium treats Consumer Healthcare as a collection of markets with distinct regulatory, clinical and commercial dynamics rather than as a homogeneous global category. The growth mechanisms available to a business depend materially on the regulatory status of the product and on the healthcare and commercial ecosystem of each individual market.

There is rarely a universal route-to-market or commercial model in Consumer Healthcare.

WHERE THE GROWTH EQUATION CHANGES
The sector lens matters because apparently similar growth questions can require very different answers.
01
Regulatory Status

Drug, medical device, nutritional supplement or another classification can materially change the growth path.

02
Evidence & Claims

Classification influences product claims, evidence requirements and communication possibilities.

03
Healthcare Ecosystem

HCP influence, market access, stakeholders and channels shape how value is created.

04
Commercial Model

Pricing, distribution, engagement and Route-to-Market need to reflect each market's specific conditions.

ADVISIUM SECTOR PERSPECTIVE

The same proposition can require a fundamentally different growth model from one country to another because classification, evidence, HCP influence, access and channel structure change the rules of the game.

CATEGORY & MARKET EXPERIENCE
Drugs
Medical Devices
Nutritional Supplements
HCP Engagement
Market Access
Go-to-Market
Market Expansion
Innovation
SELECTED ADVISIUM PERSPECTIVES
Innovation Acceleration

Prospect opportunity spaces, build platforms and bring propositions to life within regulatory and market constraints.

Market-by-market growth

Assess attractiveness alongside regulatory pathway, ecosystem, channel structure and company right-to-win.

RELATED ADVISIUM PERSPECTIVES

Discuss this growth challenge with Advisium.

Contact Advisium
Advisium

(+34) 933-823-023

info@advisiumgrowth.com

Santaló 137, Bajos. Barcelona. Spain